Amphastar Pharmaceuticals, Inc.
AMPH
$22.75
-$0.18-0.79%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 7.44% | -6.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.44% | -6.52% | |||
| Cost of Revenue | -10.33% | 3.50% | |||
| Gross Profit | 32.92% | -17.92% | |||
| SG&A Expenses | 5.41% | 11.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.48% | 6.81% | |||
| Operating Income | 191.48% | -61.72% | |||
| Income Before Tax | 283.45% | -68.50% | |||
| Income Tax Expenses | 125.66% | -51.48% | |||
| Earnings from Continuing Operations | 372.71% | -73.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 372.71% | -73.72% | |||
| EBIT | 191.48% | -61.72% | |||
| EBITDA | 93.15% | -43.98% | |||
| EPS Basic | 390.76% | -73.37% | |||
| Normalized Basic EPS | 298.27% | -68.10% | |||
| EPS Diluted | 378.57% | -72.55% | |||
| Normalized Diluted EPS | 302.88% | -68.03% | |||
| Average Basic Shares Outstanding | -3.70% | -1.27% | |||
| Average Diluted Shares Outstanding | -4.81% | -1.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||